For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220817:nRSQ3331Wa&default-theme=true
RNS Number : 3331W Tavistock Investments PLC 17 August 2022
Tavistock Investments Plc
("Tavistock" or the "Company")
Transaction in own shares and total voting rights
17 August 2022
Tavistock announces that on 17 August 2022, in accordance with the authority
granted by shareholders at the Company's Annual General Meeting held on 7
October 2021 and as signalled in the Company's 2021 final results announced on
7 September 2021, the Company has purchased 3,000,000 of its own ordinary
shares of 1 penny each ("Ordinary Shares"), representing 0.54% of the shares
in issue, at a price of 9.35 pence per share (the "Buyback Shares").
The Buyback Shares will now be cancelled and a further announcement will be
made once the cancellation has taken place.
Once the Buyback Shares have been cancelled, the Company will have 555,377,576
Ordinary Shares in issue. Therefore, the total number of voting rights in the
Company will be 555,377,576 which may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in the
Company under the FCA's Disclosure Guidance and Transparency Rules.
Assuming no further issue of Ordinary Shares, the earnings per share is
expected to increase by 0.54% per Ordinary Share as a result of this
transaction.
For further information
Tavistock Investments Plc Tel: 01753 867000
Oliver Cooke
Brian Raven
Allenby Capital Limited (Nominated adviser and broker) Tel: 020 3328 5656
Corporate Finance: Nick Naylor, Liz Kirchner, Freddie Wooding
Sales and Corporate Broking: Tony Quirke
Powerscourt Tel: 07711 380 007
Gilly Lock 020 7250 1446
Chloe Retief
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKDLBFLVLZBBB